Miraculins Announces Retail Pharmacy Pilot for Scout DS® Technology

Miraculins Inc. (TSXV:MOM) will commence a program with Lovell Drugs and Pear Healthcare Solutions for the first stand-alone, Scout DS® diabetes screening kiosks placed in Lovell’s locations in Ontario. The program will begin February 15.

As quoted in the press release:

This proof of concept pilot is being conducted to demonstrate that a stand-alone Scout DS® diabetes screening kiosk set up inside a pharmacy location, has the ability to not only deliver a rapid, non-invasive and superior diabetes screening clinic, but can be additionally purposed to generate a meaningful financial return on investment (ROI) for the pharmacy that would not have otherwise, or readily been achievable.

Click here to read the Miraculins Inc. (TSXV:MOM) press release

Click here to see the Miraculins Inc. (TSXV:MOM) profile.